Method development for the quantification of a biopharmaceutical against an auto-immune disease
Description
A novel pharmacokinetics method is being established for the quantification of a biopharmaceutical intended for the treatment of a rare auto-immune disease for a clinical trial. Non-ELISA-based methods are tested which encompass required dissociation of the drug from the auto-immune antibody with the following separation to allow drug quantification.
Key Data
Projectlead
Project status
completed, 11/2019 - 12/2020
Funding partner
Third party